LAVA Therapeutics to Participate at the Jefferies Healthcare Conference
02 June 2022 - 9:00PM
LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical stage
immuno-oncology company focused on developing its proprietary
Gammabody™ platform of bispecific gamma delta T cell engagers to
transform the treatment of cancer, today announced that Stephen
Hurly, president and chief executive officer of LAVA Therapeutics,
will participate in a fireside chat at the Jefferies Healthcare
Conference being held in New York, NY.
Presentation DetailsFormat: Fireside chat Date: Thursday, June
9, 2022Time: 11:30-11:55 a.m. EDT
A live webcast of the fireside chat can be accessed under the
"Events" tab on the investor relations section of the LAVA
Therapeutics website at:
https://ir.lavatherapeutics.com/news-events/events. A replay will
be archived for 90 days following the presentation date.
About LAVA TherapeuticsLAVA Therapeutics N.V.
is a clinical stage immuno-oncology company utilizing its
proprietary Gammabody™ platform to develop a portfolio of
bispecific gamma delta T cell engagers for the potential treatment
of solid and hematological malignancies. The Company utilizes
bispecific antibodies engineered to selectively kill cancer cells
by triggering Vγ9Vδ2 (Vgamma9 Vdelta2) T cell antitumor effector
functions upon cross-linking to tumor-associated antigens.
LAVA-051, the Company’s lead candidate for the treatment of
multiple myeloma, chronic lymphocytic leukemia and acute myeloid
leukemia, is enrolling patients in a Phase 1/2a clinical study
(NCT04887259). A Phase 1/2a clinical study to evaluate LAVA-1207 in
patients with metastatic castration-resistant prostate cancer
(mCRPC) is also enrolling (NCT05369000). For more information,
please visit www.lavatherapeutics.com, and follow us on LinkedIn,
Twitter and YouTube.
CONTACTSInvestor
Relationsir@lavatherapeutics.com
Argot Partners (IR/Media)212-600-1902lava@argotpartners.com
LAVA Therapeutics NV (NASDAQ:LVTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
LAVA Therapeutics NV (NASDAQ:LVTX)
Historical Stock Chart
From Apr 2023 to Apr 2024